Professor, Medicine, University of Vermont College of Medicine
Cardiology
Dr. Matthew W. Watkins, MD
|
|
Give Review
Doctor Matthew W. Watkins, MD practices Cardiology. He attended Perelman School of Medicine at the University of Pennsylvania. He received awards:"Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Matthew W. Watkins is a published doctor and has 43 publications published. The lastest was: 'Determinants of rebound thrombin activity after cessation of heparin in patients undergoing coronary interventions.'
Publications
- Urgent Assessment of Decision-Making Capacity in a Patient With Schizophrenia and an Evolving Myocardial Infarction Who is Refusing Care.
- Extravascular closure for patients with high-risk femoral anatomy.
- Effects of Ad5FGF-4 in patients with Angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials.
- Detection of Coronary artery stenosis using 40-channel computed tomography with multi-segment reconstruction.
- Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous Coronary intervention.
- Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of Coronary artery disease.
- Outcomes of percutaneous Coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience.
- Usefulness of platelet reactivity before percutaneous Coronary intervention in determining cardiac risk one year later.
- Lung embolization of prostate cancer brachiotherapy seeds: incidental finding during left Heart catheterization.
- Angiogenic Gene Therapy (AGENT) trial in patients with stable Angina pectoris.
- Physiologic role of the normal pericardium.
- 2,3-Butanedione monoxime increases contractile efficiency in the rabbit ventricle.
- Estimation of nonmechanical VO2 in isolated rabbit Heart: comparison of mechanical unloading and BDM method.
- Restoring forces assessed with left Atrial pressure clamps.
- Stability of myocardial O2 consumption-pressure-volume area relation in red cell-perfused rabbit Heart.
- Preload does not influence nonmechanical O2 consumption in isolated rabbit Heart.
- Effects of EMD 57033 on contraction and relaxation in isolated rabbit Hearts.
- Rapid shortening during relaxation increases activation and improves systolic performance.
- Decrease in forces responsible for diastolic suction during Acute coronary occlusion.
- Altered expression of troponin T isoforms in mild left ventricular hypertrophy in the rabbit.
- American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with Acute coronary syndromes. A report...
- Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab.
- Operator volume and outcomes in 12,998 percutaneous Coronary interventions. Northern New England Cardiovascular Disease Study Group.
- Determinants of rebound thrombin activity after cessation of heparin in patients undergoing Coronary interventions.
- Accuracy of quantitation of Aortic stenosis using femoral arterial recordings corrected for both temporal delay and systolic amplification.
- Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable Angina pectoris or provocable myocardial ischem...
- Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopenia.
- Safety and efficacy of percutaneous Coronary interventions performed immediately after diagnostic catheterization in northern new england and comparison with similar p...
- Changing outcomes in percutaneous Coronary interventions: a study of 34,752 procedures in northern New England, 1990 to 1997. Northern New England Cardiovascular Disea...
- Survival of patients with diabetes and multivessel Coronary artery disease after surgical or percutaneous Coronary revascularization: results of a large regional prosp...
- Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal Coronary angioplasty.
- Cause of in-hospital death in 12,232 consecutive patients undergoing percutaneous transluminal Coronary angioplasty. The Northern New England Cardiovascular Disease St...
- Gene therapy for Coronary artery disease: preclinical and initial clinical results with intraCoronary administration of Ad5FGF-4.
- The relationship between operator volume and outcomes after percutaneous Coronary interventions in high volume hospitals in 1994-1996: the northern New England experie...
- Multivariate prediction of in-hospital mortality after percutaneous Coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group.
- Platelet reactivity in Coronary ostial blood: a reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy.
- Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous Coronary intervention.
- Gender-related changes in the practice and outcomes of percutaneous Coronary interventions in Northern New England from 1994 to 1999.
- Predicting vascular complications in percutaneous Coronary interventions.
- A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable Angina.
- Systemic inflammation after drug-eluting stent placement.
- Two hour bivalirudin infusion after PCI for ST elevation Myocardial infarction.
Schools
Perelman School of Medicine University of Pennsylvania
Med Center Hospital Vt
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Vermont - Fletcher Allen Health Care -
Perelman School of Medicine at the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1598868499 | |
| NPPES Provider LastName | WATKINS | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 05401 | |
| NPPES Provider State | VT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 254.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598868499 |
| Last Name Of The Provider | WATKINS |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Mark A. Capeless, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Fitzgerald, MD |
|
|
Dr. Friederike K. Keating, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip A. Ades, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. William E. Hopkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keon E. Menzies, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc D. Tischler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sukit M. Ringwala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad A. Nawar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Preeth K. Sundaran, MD |
|
|
Dr. Patrick K. Hohl, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamed A. El-Haddad, MD |